Showing results (211-220 of 938) with videos related to
Sort By:
Pageof 94
Movement Disorders : Official Journal of the Movement Disorder Society|September 1, 1996
Reversal of behavioural abnormalities by fetal allografts in a novel rat model of striatonigral degenerationG K Wenning, R Granata, P M Laboyrie, et al.Neuroscience Letters|September 7, 1984
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in the common marmosetP Jenner, N M Rupniak, S Rose, et al.Psychopharmacology|January 1, 1991
Motor activity following the administration of selective D-1 and D-2 dopaminergic drugs to normal common marmosetsP A Löschmann, L A Smith, K W Lange, et al.Journal of Neurochemistry|September 1, 1989
A selective increase in particulate superoxide dismutase activity in parkinsonian substantia nigraH Saggu, J Cooksey, D Dexter, et al.Drug Design and Delivery|December 1, 1987
Multivariate statistical analysis of L-dopa esters as potential anti-parkinsonian prodrugsH Van de Waterbeemd, B Testa, C Marrel, et al.The Journal of Pharmacy and Pharmacology|October 1, 1987
L-dopa esters as potential prodrugs: effect on brain concentration of dopamine metabolites in reserpinized miceD R Cooper, C Marrel, H van de Waterbeemd, et al.The Journal of Pharmacy and Pharmacology|August 1, 1987
L-dopa esters as potential prodrugs: behavioural activity in experimental models of Parkinson's diseaseD R Cooper, C Marrel, H van de Waterbeemd, et al.Psychopharmacology|January 1, 1992
Motor activity following the administration of selective D-1 and D-2 dopaminergic drugs to MPTP-treated common marmosetsP A Löschmann, L A Smith, K W Lange, et al.Movement Disorders : Official Journal of the Movement Disorder Society|January 1, 1990
Mitochondrial DNA analysis in Parkinson's diseaseA H Schapira, I J Holt, M Sweeney, et al.Neuroreport|October 3, 1994
Time course of inhibition of brain nitric oxide synthase by 7-nitro indazoleG M MacKenzie, S Rose, P A Bland-Ward, et al.Pageof 94